[시장보고서]세계의 동물 의료용 단클론항체 시장 : 동물 유형, 용도, 최종사용자, 지역별 분석, 경쟁 구도 및 예측(2023-2033년)

세계의 동물 의료용 단클론항체 시장 : 동물 유형, 용도, 최종사용자, 지역별 분석, 경쟁 구도 및 예측(2023-2033년)

Global Monoclonal Antibodies in Veterinary Health Market: Focus on Animal Type, Application, and End User, Regional Analysis, and Competitive Landscape - Analysis and Forecast, 2023-2033

상품코드 : 1446135

리서치사 : BIS Research

발행일 : On Demand Report

페이지 정보 : 영문

라이선스 & 가격 (부가세 별도)

ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.

ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

샘플 요청 목록에 추가

세계 동물 의료용 단클론항체(Monoclonal Antibody) 시장을 조사했으며, 시장 개요, 주요 동향, 규제 환경, 시장 영향요인 및 시장 기회 분석, 시장 규모 추이 및 예측, 각종 부문별/지역별 상세 분석, 경쟁 구도, 주요 기업 개요 등의 정보를 정리하여 전해드립니다.

영문목차

The report on the global monoclonal antibodies in veterinary health market provides a thorough analysis of the market, providing insights into current trends, a future impact assessment, patent filing trends, and regulatory requirements for the market. It explores the impact of key global events, identifies driving factors and challenges affecting market growth, and highlights growth opportunities.

It profiles key market players and their strategies for market dominance, including a competitive analysis. The report also examines regional segmentation, estimating market presence and performance across different geographical regions worldwide, and discusses potential investment opportunities for shareholders and investors.

This report focuses on nurturing a profound understanding of market dynamics and serves as a valuable resource for business ventures, entrepreneurs, and industries looking for detailed insights into the monoclonal antibodies in veterinary health market.

Market Segmentation:

Segmentation 1: by Application

Dermatology
Pain
Others

Segmentation 2: by Animal Type

Dog
Others

Segmentation 3: by End User

Veterinary Hospitals
Others

Segmentation 3: by Region

North America
Europe
Asia-Pacific
Latin America
Middle East and Africa

Key Questions Answered:

What are the major driving factors, opportunities, and restraints in the global monoclonal antibodies in veterinary health market?
How will the market evolve during the forecast period, and what are its future prospects?
What are the key players of the market and their key developmental strategies which pose them as the key players of the market?
How will the segments evolve during the forecast period?
Which segments hold a prominent market share and what factors are influencing their growth in the market?

Executive Summary

Scope of the Study

Research Methodology

1. Global Monoclonal Antibodies in Veterinary Health Market: Overview

1.1 Product Definition
1.2 Inclusion and Exclusion Criteria
1.3 Key Findings

2. Global Monoclonal Antibodies in Veterinary Health Market: Industry Analysis

2.1 Regulatory Requirements
2.2 Key Trends
2.3 Impact of COVID-19 on Global Monoclonal Antibodies in Veterinary Health Market

3. Global Monoclonal Antibodies in Veterinary Health Market: Market Dynamics

3.1 Overview
3.2 Impact Analysis
3.3 Market Drivers
3.4 Market Restraints
3.5 Market Opportunities

4. Global Monoclonal Antibodies in Veterinary Health Market (by Animal Type)

4.1 Overview
4.2 Growth-Share Matrix
4.3 Dog
4.4 Others

5. Global Monoclonal Antibodies in Veterinary Health Market (by Application)

5.1 Overview
5.2 Growth-Share Matrix
5.3 Dermatology
5.4 Pain
5.5 Others

6. Global Monoclonal Antibodies in Veterinary Health Market (by End User)

6.1 Overview
6.2 Growth-Share Matrix
6.3 Veterinary Hospitals
6.4 Others

7. Global Monoclonal Antibodies in Veterinary Health Market, (by Region)

7.1 Overview
7.2 North America Monoclonal Antibodies in Veterinary Health Market
- 7.2.1 Overview
- 7.2.2 Market Size and Forecast
  - 7.2.2.1 North America Monoclonal Antibodies in Veterinary Health Market, by Country
    - 7.2.2.1.1 U.S.
    - 7.2.2.1.2 Canada
7.3 Europe
- 7.3.1 Overview
- 7.3.2 Market Size and Forecast
  - 7.3.2.1 Europe Monoclonal Antibodies in Veterinary Health Market, by Country
    - 7.3.2.1.1 Germany
    - 7.3.2.1.2 U.K.
    - 7.3.2.1.3 France
    - 7.3.2.1.4 Italy
    - 7.3.2.1.5 Spain
    - 7.3.2.1.6 Rest of Europe
7.4 Asia-Pacific
- 7.4.1 Overview
- 7.4.2 Market Size and Forecast
  - 7.4.2.1 Asia-Pacific Monoclonal Antibodies in Veterinary Health Market, by Country
    - 7.4.2.1.1 China
    - 7.4.2.1.2 Japan
    - 7.4.2.1.3 India
    - 7.4.2.1.4 South Korea
    - 7.4.2.1.5 Australia and New Zealand
    - 7.4.2.1.6 Rest of Asia-Pacific
7.5 Latin America
- 7.5.1 Overview
- 7.5.2 Market Size and Forecast
  - 7.5.2.1 Latin America Monoclonal Antibodies in Veterinary Health Market, by Country
    - 7.5.2.1.1 Brazil
    - 7.5.2.1.2 Mexico
    - 7.5.2.1.3 Rest of Latin America
7.6 Middle East and Africa
- 7.6.1 Overview
- 7.6.2 Market Size and Forecast
  - 7.6.2.1 Middle East and Africa Monoclonal Antibodies in Veterinary Health Market, by Country
    - 7.6.2.1.1 U.A.E
    - 7.6.2.1.2 South Africa
    - 7.6.2.1.3 Rest-of-Middle East and Africa

8. Global Monoclonal Antibodies in Veterinary Health Market: Competitive Insights and Company Profiles

8.1 Global Monoclonal Antibodies in Veterinary Market Active Players Ecosystem
8.2 Key Strategies and Developments
- 8.2.1 Overview
- 8.2.2 Collaborations and Partnerships
- 8.2.3 Acquisitions and Mergers
- 8.2.4 Business Expansions
- 8.2.5 Product Launches
- 8.2.6 Funding
8.3 Company Profiles
- 8.3.1 Merck & Co, Inc.
  - 8.3.1.1 Company Overview
  - 8.3.1.2 Product Portfolio
  - 8.3.1.3 Financials
  - 8.3.1.4 Recent Developments
  - 8.3.1.5 Analyst View
- 8.3.2 Zoetis
- 8.3.3 Elanco
- 8.3.4 Boehringer Ingelheim GmbH
- 8.3.5 Virbac
- 8.3.6 Invetx
- 8.3.7 Indian Immunologicals Ltd.
- 8.3.8 Other Companies

한글목차

목차

주요 요약

조사 범위

제1장 세계의 동물 의료용 단클론항체 시장 : 개요

제2장 세계의 동물 의료용 단클론항체 시장 : 산업 분석

제3장 세계의 동물 의료용 단클론항체 시장 : 시장 역학

제4장 세계의 동물 의료용 단클론항체 시장 : 동물 유형별

제5장 세계의 동물 의료용 단클론항체 시장 : 용도별

제6장 세계의 동물 의료용 단클론항체 시장 : 최종사용자별

제7장 세계의 동물 의료용 단클론항체 시장 : 지역별

제8장 세계의 동물 의료용 단클론항체 시장 : 경쟁 인사이트·기업 개요